An imbalance between matrix metalloproteinase-2
and tissue inhibitor of matrix metalloproteinase-2
contributes to the development of early diabetic nephropathy.
Prognostic significance of matrix metalloproteinase-2
,-8,-9, and-13 in oral tongue cancer.
expression in the left and right ventricles in response to different treatments
Zhang, "Type IV collagenase (matrix metalloproteinase-2
and -9) in prostate cancer," Prostate Cancer and Prostatic Diseases, vol.
Petronijevic et al., "Matrix metalloproteinase-2
(MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer," Molecular and Cellular Biochemistry, vol.
Plasma levels of matrix metalloproteinase-2
and tissue inhibitor of metalloproteinase-1 correlate with disease stage and survival in colorectal cancer patients.
Chong, "The amyloid-[beta] peptide suppresses transforming growth factor-[beta]1-induced matrix metalloproteinase-2
production via Smad7 expression in human monocytic THP-1 cells," Journal of Biological Chemistry, vol.
To examine protein expression of stromal cell-derived factor 1 (SDF-1), basic fibroblast growth factor (bFGF/FGF2) and matrix metalloproteinase-2
(MMP2) ELISAs (all DuoSet, R&D Systems, Minnesota, USA) were performed according to the manufacturer's instructions.
Watkins, "Identification of novel, functional genetic variants in the human matrix metalloproteinase-2
gene: role of Sp1 in allele-specific transcriptional regulation," Journal of Biological Chemistry, vol.
Morning fasting venous blood samples were collected to measure MMP-1 (matrix metalloproteinase-1), MMP-2 (matrix metalloproteinase-2
), TIMP-1 (tissue inhibitor of metalloproteinase-1), MMP-9 (matrix metallopeptidase-9), BDNF (brain-derived neurotrophic factor), GDNF (glial cell line-derived neurotrophic factor), and VEGF (vascular endothelial growth factor).
Sahin, "Matrix metalloproteinase-2
, tissue inhibitor of matrix metalloproteinase- 2, and transforming growth factor beta 1 in the aqueous humor and serum of patients with pseudoexfoliationsyndrome," Clinical Ophthalmology, vol.
(MMP2), one of the most ubiquitous members of the matrix metalloproteinase family, cleaves collagen type IV of the extracellular matrix maintaining equilibrium between matrix synthesis and degradation, thus providing a critical role in the cell integrity and cell survival (Malemud, 2006).